Keyphrases
COVID-19
71%
Acute Respiratory Distress Syndrome
67%
Bronchoalveolar Lavage
66%
Influenza
54%
Respiratory Failure
45%
Seasonal Influenza
42%
Critically Ill Patients
40%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
30%
Intubation
28%
Mechanical Ventilation
28%
Severe COVID-19
27%
Interleukin-6
26%
Lower Airways
25%
Narrative Review
25%
Severe Disease
24%
Cytokine Concentration
24%
Gram-negative Bacteria
23%
Interleukin-6 Levels
20%
COVID-19 Phenotypes
20%
Mechanically Ventilated Patients
20%
Interleukin-6 Inhibitors
20%
Respiratory Infection
20%
Pulmonary Consolidation
20%
Gram-negative
20%
Secondary Infection
20%
Extensively Drug-resistant
20%
Multidrug-resistant
20%
Young Patients
20%
Cytokine Storm
20%
Complement Activation
20%
Histoplasmosis
20%
Severe Acute Respiratory Distress Syndrome
20%
Immunocompromised Host
20%
Human Respiratory Tract
20%
Propensity Score Matching Study
20%
Human Patients
20%
Epidemiology
20%
Inflammatory Profile
20%
SARS-CoV-2 Infection
20%
Patients at Risk
20%
Respiratory Viral Infection
20%
Distinctive Features
20%
Low Risk
20%
Pseudomonas Aeruginosa (P. aeruginosa)
20%
Older Patients
20%
Obstructive Sleep Apnea
20%
Quantitative PCR
20%
Multicenter Cohort Study
20%
Emergency Department
20%
Bronchoalveolar
20%
Medicine and Dentistry
COVID-19
100%
Lung Lavage
73%
Respiratory Failure
64%
Acute Respiratory Distress Syndrome
62%
Severe Acute Respiratory Syndrome Coronavirus 2
60%
Infection
52%
Cytokine
42%
Seasonal Influenza
40%
Artificial Respiration
31%
Diseases
29%
Extracorporeal Membrane Oxygenation
26%
Interleukin 6
26%
Intubation
24%
Outpatient
22%
Steady State
20%
Complement Activation
20%
Reverse Transcription Polymerase Chain Reaction
20%
Respiratory Tract Infection
20%
Pulmonary Consolidation
20%
Emergency Department
20%
Pneumocystis Pneumonia
20%
Viral Respiratory Tract Infection
20%
Gram-Negative Bacteria
20%
Receptor Blocking Agent
20%
Secondary Infection
20%
Cytokine Storm
20%
Interleukin 6 Receptor
20%
Antimicrobial Therapy
20%
Immunocompromised Patient
20%
Itraconazole
20%
Computer Assisted Tomography
20%
Broad-Spectrum Antibiotic
20%
Dyspnea
20%
Lung Biopsy
20%
Lobar Pneumonia
20%
Uveitis
20%
Methotrexate
20%
Coughing
20%
Prostacyclin
20%
Nasopharyngeal Swab
17%
Lung
13%
Hypoxemia
13%
Immune Response
12%
Bronchoscopy
12%
Ventilator Induced Lung Injury
10%
Nasal Cannula
10%
Tocilizumab
9%
Antiinfective Agent
8%
Pathogen
8%
Antibiotic Resistance
8%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
60%
Infection
56%
Respiratory Failure
48%
Diseases
44%
Cytokine
42%
Coronavirinae
40%
Adult Respiratory Distress Syndrome
40%
Interleukin 6
26%
Seasonal Influenza
22%
Pseudomonas aeruginosa
20%
Interleukin 6 Receptor
20%
Secondary Infection
20%
Pseudomonas Infection
20%
Acute Kidney Failure
20%
Cytokine Storm
20%
Receptor Blocking Agent
20%
Sleep Disordered Breathing
20%
Respiratory Tract
20%
Viral Respiratory Tract Infection
20%
Oseltamivir
20%
Prostacyclin
20%
Endothelium Injury
13%
Hypercoagulability
13%
Tocilizumab
9%
Immune Dysregulation
8%
Antiviral Drug
7%
Intubation
7%
Alpha 2 Macroglobulin
6%
Thrombomodulin
6%
Von Willebrand Factor
6%
Immunoglobulin
6%
Critical Illness
6%
Angiopoietin 2
6%
Immunoglobulin A
6%
Immunoglobulin M
6%
Clinical Trial
6%
Acute Respiratory Failure
6%
Drug Discovery
6%
